News
Discovery may open the way for new treatments for multiple sclerosis, leukodystrophies OHSU researchers discover a gene that ...
Transmembrane proteins (TPs), also referred to as ‘integral membrane proteins’, make up between 70 % and 80 % of the total ...
Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 ...
A new once daily triple drug treatment for cystic fibrosis is set to be “immediately funded” by NHS England following recommendation from the National Institute for Health and Care Excellence (NICE).1 ...
Scientists developed a fast, cell-free system to create virus-mimicking vaccines, enabling quicker responses to emerging ...
NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...
Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle vaccines that mimic viruses ...
Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) -- -- Prime Medicin ...
STUTTGART, Germany I July 21, 2025 I La Merie Publishing released its newest product entitled: TL1A Inhibitors & DR3 Antagonists: a Competitor Analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results